Biodesix Inc 's (BDSX) Outlook - CSIMarket
CSIMarket
 
Biodesix Inc   (NASDAQ: BDSX)
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare
 



  Biodesix Inc Outlook

On January 10 2025 the Biodesix Inc provided following guidance

Biodesix Inc. has recently announced its preliminary financial results for the fourth quarter and the entirety of 2024, emphasizing significant growth in revenue. According to the provided financial guidance, the company anticipates generating approximately $71.3 million in revenue for the full year of 2024. This figure marks a remarkable increase of 45% compared to the previous year.

The impressive growth in revenue underscores Biodesix's ongoing commitment to expanding its market presence and enhancing its product offerings. This substantial rise not only indicates the company's successful strategies in driving sales but also reflects the increasing demand for its innovative solutions in the diagnostics sector. With such robust financial performance, Biodesix is positioning itself strongly for continued success and sustainability in the years to come.,





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.